|
Sex
|
Model 1
|
Model 2
|
Model 3
|
Model 4
|
Model 5
|
Model 6
|
|---|
|
2.255*** (1.725–2.947)
|
1.923*** (1.457–2.538)
|
2.194*** (1.649–2.919)
|
2.054*** (1.564–2.698)
|
1.977*** (1.502–2.603)
|
1.549*** (1.141–2.105)
|
|---|
|
(A) CVD
|
|
Smoking
| |
2.431*** (1.762–3.355)
| | | |
2.405*** (1.727–3.349)
|
|
Obesity
| | |
1.041 (0.785–1.361)
| | |
1.172 (0.878–1.565)
|
|
Grade II hypertension
| | |
1.264 (0.959–1.667)
| | |
1.237 (0.932–1.642)
|
|
Cholesterol
| | |
0.931 (0.704–1.230)
| | |
0.934 (0.705 – 1.236)
|
|
TG
| | |
1.108 (0.671–1.828)
| | |
1.192 (0.721 – 1.969)
|
|
Reported MI
| | | |
1.470* (1.062–2.034)
| |
1.375 (0.988–1.912)
|
|
Reported stroke
| | | |
1.747** (1.236–2.470)
| |
1.823** (1.287–2.581)
|
|
ST depression
| | | |
1.506* (1.071–2.117)
| |
1.473* (1.040–2.086)
|
|
VPC ≥ 10/h
| | | | |
1.381* (1.034–1.844)
|
1.333 (0.992–1.791)
|
|
Polymorphic VPC
| | | |
1.256 (0.957–1.650)
|
1.179 (0.894–1.554)
|
|
VPC runs
| | | | |
2.196*** (1.518–3.180)
|
2.228*** (1.523–3.259)
|
|
N
|
1732
|
1732
|
1726
|
1727
|
1729
|
1720
|
|
Reduction of M/F HR compared to Model 1, %
|
-
|
14.7
|
2.7
|
8.9
|
12.3
|
31.3
|
|
Sex
|
Model 1
|
Model 2
|
Model 3
|
Model 4
|
Model 5
|
Model 6
|
|---|
|
2.193*** (1.788–2.689)
|
1.932*** (1.564–2.386)
|
2.185*** (1.759–2.715)
|
2.084*** (1.693–2.565)
|
1.994*** (1.618–2.458)
|
1.704*** (1.352–2.148)
|
|---|
|
(B) All causes
|
|
Smoking
| |
2.058**** (1.600–2.647)
| | | |
2.059**** (1.593–2.662)
|
|
Obesity
| | |
1.001 (0.805–1.245)
| | |
1.071 (0.857–1.339)
|
|
Grade II hypertension
| | |
1.136 (0.913–1.412)
| | |
1.108 (0.887–1.385)
|
|
Total cholesterol
| | |
1.000 (0.809–1.236)
| | |
0.986 (0.796 – 1.221)
|
|
Triglycerides
| | |
0.897 (0.595–1.354)
| | |
0.944 (0.625 – 1.426)
|
|
Reported MI
| | | |
1.208 (0.920–1.586)
| |
1.132 (0.859–1.492)
|
|
Reported stroke
| | | |
1.549** (1.162–2.065)
| |
1.565** (1.172–2.092)
|
|
ST depression
| | | |
1.461** (1.110–1.922)
| |
1.427* (1.079–1.885)
|
|
VPC ≥ 10/h
| | | | |
1.131 (0.894–1.431)
|
1.100 (0.866–1.397)
|
|
Polymorphic VPC
| | | |
1.283* (1.040–1.582)
|
1.225 (0.991–1.515)
|
|
VPC runs
| | | | |
1.904*** (1.400–2.592)
|
1.947*** (1.422–2.666)
|
|
N
|
1732
|
1732
|
1726
|
1727
|
1729
|
1720
|
|
Reduction of M/F HR compared to Model 1, %
|
-
|
11.9
|
0.4
|
5.0
|
9.1
|
22.2
|
- *p < 0.05; **p < 0.01; ***p < 0.001
- Model 1: Adjusted for age and education
- Model 2: Adjusted for age, education, and smoking
- Model 3: Adjusted for age, education, obesity, grade II hypertension, total cholesterol, and triglycerides
- Model 4: Adjusted for age, education, reported MI and stroke, and ST depression
- Model 5: Adjusted for age, education, VPC ≥ 10/h, polymorphic VPC, and VPC runs
- Model 6: Adjusted for age, education, smoking, obesity, grade II hypertension, total cholesterol, triglycerides, reported MI and stroke, ST depression, VPCs ≥ 10/h, polymorphic VPC, and VPC runs
